德英生物科技
News

Events

2025.06.13

Events

G&E Biotech Successfully Holds 2025 Annual Shareholders’ Meeting

We sincerely thank all our guests for their valuable insights and unwavering support.

G&E Herbal Biotech Chairman Dr. Kou-Wha, Kuo (formerly Biochemistry Professor at Kaohsiung Medical University) shared updates on the SR-100 product series and R&D progress during the meeting:

  • Presented achievements including SR-100 Smile CreamSR-100 SolaVision, signature Eye Care Products, and functional skincare products
  • Achieving solid revenue results with resounding shareholder endorsement
  • Continued advancement of the internationally innovative development of the Malignant Ascites Injection New Drug (SR-T100)
Shareholders’ Meeting Photo 1
Shareholders’ Meeting Photo 2
Shareholders’ Meeting Photo 3